202
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Targeted sequencing analysis of ACVR2A gene identifies novel risk variants associated with preeclampsia

, , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 2790-2796 | Received 03 Jan 2018, Accepted 04 Mar 2018, Published online: 21 Mar 2018

References

  • Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376:631–644.
  • Duley L. Pre-eclampsia, eclampsia, and hypertension. BMJ Clin Evid. 2011;2:1402.
  • Leitner Y, Harel S, Geva R, et al. The neurocognitive outcome of IUGR children born to mothers with and without preeclampsia. J Matern Fetal Neonatal Med. 2012;25:2206–2208.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466–480.
  • Buurma AJ, Turner RJ, Driessen JH, et al. Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update. 2013;19:289–303.
  • Giannakou K, Evangelou E, Papatheodorou SI. Genetic and non-genetic risk factors for pre-eclampsia: an umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol. 2017 [Nov 16]. DOI:10.1002/uog.18959
  • Medica I, Kastrin A, Peterlin B. Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2007;131:115–126.
  • Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–474.
  • Williams PJ, Broughton Pipkin F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:405–417.
  • Roten LT, Fenstad MH, Forsmo S, et al. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod. 2011;17:439–446.
  • Fong FM, Sahemey MK, Hamedi G, et al. Maternal genotype and severe preeclampsia: a HuGE review. Am J Epidemiol. 2014;180:335–345.
  • Sandoval-Carrillo A, Aguilar-Duran M, Vázquez-Alaniz F, et al. Polymorphisms in the GSTT1 and GSTM1 genes are associated with increased risk of preeclampsia in the Mexican mestizo population. Genet Mol Res. 2014;13:2160–2165.
  • Moses EK, Lade JA, Guo G, et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet. 2000;67:1581–1585.
  • Moses EK, Fitzpatrick E, Freed KA, et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod. 2006;12:505–512.
  • Peng C, Huang TH, Jeung EB, et al. Expression of the type II activin receptor gene in the human placenta. Endocrinology. 1993;133:3046–3049.
  • Yong HEJ, Murthi P, Kalionis B, et al. Decidual ACVR2A regulates extravillous trophoblast functions of adhesion, proliferation, migration and invasion in vitro. Pregnancy Hypertens. 2017;17:S2210–S7789.
  • Grobman WA, Wang EY. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol. 2000;96:390–394.
  • Muttukrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod. 2000;15:1640–1645.
  • Yong HE, Murthi P, Wong MH, et al. Effects of normal and high circulating concentrations of activin A on vascular endothelial cell functions and vasoactive factor production. Pregnancy Hypertens. 2015;5:346–353.
  • Fitzpatrick E, Johnson MP, Dyer TD, et al. Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia. Mol Hum Reprod. 2009;15:195–204.
  • Roten LT, Johnson MP, Forsmo S, et al. Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur J Hum Genet. 2009;17:250–257.
  • Lokki AI, Klemetti MM, Heino S, et al. Association of the RS1424954 polymorphism of the ACVR2A gene with the risk of pre-eclampsia is not replicated in a Finnish study population. BMC Res Notes. 2011;4:545.
  • Zeybek B, Celik HA, Aydin HH, et al. Polymorphisms in the activin A receptor type 2A gene affect the onset time and severity of preeclampsia in the Turkish population. J Perinat Med. 2013;41:389–399.
  • Ferreira LC, Gomes CE, Araújo AC, et al. Association between ACVR2A and early-onset preeclampsia: replication study in a Northeastern Brazilian population. Placenta. 2015;36:186–190.
  • ACOG Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet. 2002;77:67–75.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated Cells. Nucleic Acids Res. 1988;16:1215.
  • Glotov AS, Vashukova ES, Danilova MM, et al. Application of NGS method for ACVR2A gene sequencing in women with preeclampsia. Mol Med. 2014;5:33–40.
  • Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079.
  • Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics. 2011;27:2156–2158.
  • Cingolani P, Patel VM, Coon M, et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Front Genet. 2012;3:35.
  • Wang K, Li M, Hakonarson HH. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.
  • Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell. 2015;58:586–597.
  • Glotov AS, Kazakov SV, Zhukova EA, et al. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clin Chim Acta. 2015;446:132–140.
  • Miller EM, Patterson NE, Zechmeister JM, et al. Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants. Oncotarget. 2017;8:102033–102045.
  • Manuelpillai U, Schneider-Kolsky M, Dole A, et al. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. J Endocrinol. 2001;171:57–64.
  • Brennecke SP, Yong HE, Murthi P, et al. 2A expression modifies the response of vascular endothelial cells to normotensive and preeclamptic activin a concentrations. Pregnancy Hypertens. 2016;6:161.
  • Thulluru HK, Michel OJ, Oudejans CB, et al. ACVR2A promoter polymorphism RS1424954 in the activin-A signaling pathway in trophoblasts. Placenta. 2015;36:345–349.
  • Bai Y, Yang W, Yang HX, et al. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One. 2012;7:e38875.
  • Vashukova ES, Glotov AS, Fedotov PV, et al. Placental microRNA expression in pregnancies complicated by superimposed pre-eclampsia on chronic hypertension. Mol Med Rep. 2016;14:22–32.
  • Millat G, Chanavat V, Rousson R. Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies. Clin Chim Acta. 2014;433:266–271.
  • Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49:433–436.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.